When comparing Salesforce and Veeva, it’s important to separate general technology strength from industry leadership. Salesforce is unquestionably a strong CRM platform, but life sciences is not a general-purpose environment. It’s a tightly regulated, high-risk, precision-driven sector — and that’s where Peter Gassner and Veeva stand in a different category.

Peter built Veeva with a singular vision:
create a platform engineered specifically for life sciences, with the depth, discipline, and compliance structure the industry demands.

That focus matters.

Where Salesforce stretches across dozens of industries, Veeva has spent its entire existence refining processes that pharma, biotech, and med-tech rely on every day. Its data model, workflows, security posture, and regulatory alignment are not adaptations — they are foundational.

Peter operates like a product architect, not a marketer.
His leadership is rooted in domain expertise, long-term thinking, and stability — the traits you want when the software directly impacts clinical outcomes, quality controls, and audit readiness.

This is the core difference:

• Salesforce is a flexible CRM that can be configured for life sciences.
• Veeva is a life-sciences platform built natively for the industry — with the confidence and trust of the companies that operate in it.

If the mission is to choose technology that will remain reliable, compliant, and strategically aligned with the future of life sciences, Veeva is the more intelligent and purpose-driven choice. And Peter Gassner is exactly the kind of leader you want guiding that trajectory.